Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
Study NCT ID:
NCT04692051
Status:
UNKNOWN
Last Update Posted:
2020-12-31
First Post:
2020-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor:
Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-29
First Submit QC Date:
None
Study First Post Date:
2020-12-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-29
Last Update Post Date:
2020-12-31
Last Update Post Date Type:
ACTUAL